Results of the Annual General Meeting and change to the Board of Directors
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)
RESULTS OF THE ANNUAL GENERAL MEETING AND CHANGE TO THE BOARD OF DIRECTORS
Results of the AGM
Shareholders are hereby advised that the annual general meeting of the Company was held at
10:00 today, 30 November 2022, via electronic communication (“AGM”).
Shareholders are further advised that at the AGM all of the resolutions were passed by the
requisite majorities of the Company’s shareholders, save for Ordinary resolution number 2,
Special resolution number 2 and Special resolution number 3, which were not passed by the
requisite majorities of the Company’s shareholders.
Details of the results of the voting at the AGM are as follows:
Resolutions Shares Shares Votes for Votes Shares
proposed at the AGM voted at voted (%) 1 resolution against abstained
General (%) 2 resolution (%)1
Meeting (%) 2
(number)
Ordinary resolution 379 846 004 60.84% 77.20% 22.80% 0.33%
number 1: Re-
appointment of
auditors
Ordinary resolution 316 881 217 50.75% 20.16% 79.84% 10.42%
number 2: Re-election
of retiring non-
executive director,
Harry Smit
Ordinary resolution 379 446 004 60.77% 80.01% 19.99% 0.40%
number 3: Re-election
of retiring non-
executive director,
Karsten Wellner
Ordinary resolution 379 416 004 60.77% 99.66% 0.34% 0.40%
number 4.1:
Appointment of Bharti
Harie as a member of
the audit and risk
committee
Ordinary resolution 379 416 004 60.77% 99.69% 0.31% 0.40%
number 4.2:
Appointment of
Amaresh Chetty as a
member of the audit
and risk committee
Ordinary resolution 335 358 356 53.71% 55.16% 44.84% 7.46%
number 4.3:
Appointment of
Lawrence Mulaudazi
as a member of the
audit and risk
committee
Ordinary resolution 379 446 004 60.77% 80.03% 19.97% 0.40%
number 4.4:
Appointment of
Karsten Wellner as a
member of the audit
and risk committee
Ordinary resolution 380 102 025 60.88% 79.55% 20.45% 0.29%
number 5: General but
restricted authority
to place unissued
shares under the
control of director,
limited to 10%
Ordinary resolution 318 085 233 50.94% 95.77% 4.23% 10.22%
number 6:
Endorsement of
Ascendis Health
Remuneration Policy
Ordinary resolution 318 085 233 50.94% 96.25% 3.75% 10.22%
number 7:
Endorsement of
Ascendis Health
Remuneration
Implementation Report
Special resolution 318 617 077 51.03% 97.55% 2.45% 10.14%
number 1: Approval of
non-executive
directors’ remuneration
for FY23
Special resolution 379 975 880 60.86% 65.33% 34.67% 0.31%
number 2: Approval of
financial assistance in
terms of section 44 of
the Act
Special resolution 379 975 880 60.86% 65.33% 34.67% 0.31%
number 3: Approval of
financial assistance in
terms of section 45 of
the Act
Additional ordinary 379 732 763 60.82% 83.58% 16.42% 0.35%
resolution number 8:
Change to Board of
Directors, appointment
of Theunis de Bruyn
Note:
1. As a percentage of the total number of shares in issue as at the date of the AGM (excluding
treasury shares).
2. As a percentage of the total number of shares voted at the AGM.
3. The total number of shares in issue as at the date of the AGM was 632,469,959 ordinary
shares of which 8,091,150 were treasury shares. Accordingly, the total votable shares were
624,378,809 ordinary shares.
4. No resolutions were added or amended at the AGM.
Change to Board of Directors
In accordance with paragraph 3.59 of the Listings Requirements of the JSE Limited, shareholders
are hereby advised the Mr. Harry Smit is no longer an independent non-executive director of the
Company or the chairman of the board of directors of the Company (“Board”), with effect from
today, 30 November 2022.
The Board thanks Mr. Harry Smit for his contributions to Ascendis Health during his tenure of
service and wishes him well in his future endeavours.
30 November 2022
Johannesburg
Sponsor
Valeo Capital (Pty) Limited
Date: 30-11-2022 05:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.